Constitutive Androstane Receptor (car) As a Therapeutic Target for Obesity and Type Two Diabetes
The invention provides a method of controlling obesity or type two diabetes in a human. In accordance with the inventive method, the constitutive androstane receptor (CAR) is agonized within the human, which effectively controls obesity or type two diabetes.
Attached files:Patents:WO 2,010,059,662
Inventor(s):
XIE WEN [US]; GAO JIE [US]
Type of Offer:
Licensing
« More Medical Patents